Drug development in biotechnology takes time. A lot of time. On average, it takes 10 to 15 years to take a medicine from ...
Baylor College of Medicine will be a site for a new multi-institution project aimed at investigating preclinical drug safety ...
Funding backs a human-first approach to drug safety and efficacy, reducing reliance on animal testing and accelerating therapies for patients. NEW HAVEN, CT / ACCESS Newswire / December 5, 2025 / ...
Healthcare is in the midst of a data-driven revolution. With the convergence of big data, machine learning and AI, the sector is becoming smarter, faster and more predictive. These technologies are ...
Drug discovery is a high-risk, high-cost endeavor, with over 90% of candidates failing in clinical development. A significant proportion of these failures stem from unresolved biopharmaceutic ...
Large language models (LLMs) can be broadly applied across multiple key stages in drug development: (1) Target identification and drug screening. Llama-Gram, GPCR LLM, and ProtChat systems effectively ...
Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
Ebrahimi is a scientific leader at GSK. Mrksich is the Henry Wade Rogers professor at Northwestern University, where he is developing the MegaMolecule technology for creating multifunctional ...
A particle accelerator that produces intense X-rays could be squeezed into a device that fits on a table, my colleagues and I have found in a new research project. The way that intense X-rays are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback